Bioactive Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, GLP-1 receptor agonists, with potential therapeutic efficacy in type 2 diabetes mellitus (T2DM).
Use
Action Somaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, and its effect in the treatment of type 2 diabetes is better.
